Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.82)
# 1,648
Out of 5,127 analysts
26
Total ratings
62.5%
Success rate
19%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $490.83 | -29.91% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $23.47 | +127.95% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $30.50 | +31.15% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $31.76 | -5.54% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $7.00 | +21.43% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $21.48 | -25.51% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.19 | +48,916.02% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $340 → $460 | $0.95 | +48,097.82% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $7.53 | +577.29% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $35.57 | -55.02% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $5.61 | +702.14% | 1 | Jan 22, 2020 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $490.83
Upside: -29.91%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $23.47
Upside: +127.95%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $30.50
Upside: +31.15%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $31.76
Upside: -5.54%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $7.00
Upside: +21.43%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $21.48
Upside: -25.51%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.19
Upside: +48,916.02%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $340 → $460
Current: $0.95
Upside: +48,097.82%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $7.53
Upside: +577.29%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $35.57
Upside: -55.02%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $5.61
Upside: +702.14%